RxDoctor Payments Data

Mallory Booth, PA

Medical · Macon, GANPI 1073960118

Payments from drug & device makers

$5,684in general payments, 2019–2025

Across 290 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$468
  • Merck$352
  • Novartis$349
  • Seagen Inc.$342
  • Incyte Corporation$315
  • Johnson & Johnson$272
  • plus $4K from 53 others

What the payments were for

  • Food & beverage$5,13290%
  • Education$55210%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie30$468
Merck17$352
Novartis15$349
Seagen Inc.17$342
Incyte Corporation10$315
Johnson & Johnson17$272
Sanofi-aventis U.S. LLC2$197
Bristol Myers Squibb10$191
AstraZeneca(2 entities)10$180
Daiichi Sankyo Inc.7$165
Abbott12$162
Exelixis Inc.3$145
Amgen9$144
GSK8$136
Eisai Inc.8$136
Genentech USA, Inc.6$126
Boston Scientific7$125
Regeneron Healthcare Solutions, Inc.5$123
Sanofi7$123
Bayer6$103
Pfizer7$100
E.r. Squibb & Sons, L.L.C.5$96
Jazz Pharmaceuticals Inc.3$82
Karyopharm Therapeutics Inc.3$64
Myriad Genetic Laboratories, Inc.4$64
Redhill Biopharma Inc.4$58
Takeda Pharmaceuticals U.S.A., Inc.2$57
AVEO Pharmaceuticals, Inc.2$56
Coherus Oncology, Inc.3$54
Collegium Pharmaceutical, Inc.4$54
Tersera Therapeutics LLC2$51
Teva Pharmaceuticals USA, Inc.3$50
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC3$49
Lilly USA, LLC2$48
Beigene USA, Inc.2$39
Almatica Pharma LLC2$39
Blueprint Medicines Corporation2$38
Astellas Pharma US Inc2$36
ADC Therapeutics America, Inc.2$32
Servier Pharmaceuticals LLC2$32
Si-bone, Inc.2$32
Biodelivery Sciences International, Inc.2$30
Biohaven Pharmaceuticals, Inc.2$30
Mirati Therapeutics, Inc.2$29
Emmaus Medical, Inc.1$28
Organon1$28
Puma Biotechnology, Inc.2$27
Scilex Pharmaceuticals Inc.2$26
Foundation Medicine, Inc.1$22
Taiho Oncology, Inc.1$21
Stemline Therapeutics Inc.1$21
Baudax Bio Inc.1$19
G1 Therapeutics, Inc.1$19
Gilead1$18
Morphosys, US Inc.1$18
Adaptive Biotechnologies Corporation1$17
Pacira Therapeutics, Inc.1$17
Lundbeck LLC1$16
Deciphera Pharmaceuticals Inc.1$15

How this compares

$5,684 in reported general payments places this provider in the 85th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$5,487
Medicare patients
39
Services billed
107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl13$508
Fluticasone Propionate25$441

Paid to pharmacies, not to this prescriber.

Other medical in Macon

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →